AMTX - Aemetis, Inc.
NASDAQ
->
Energy
->
Oil & Gas Refining & Marketing
Cupertino,
United States
Type: Equity
AMTX price evolution
AMTX
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.23 | $1.63 | $2.67 | $3.9 |
| Short term investments | ||||
| Net receivables | $8.76 | $8.87 | $8.63 | $4.58 |
| Inventory | $10.24 | $16.01 | $18.29 | $8.14 |
| Total current assets | $23.86 | $32.95 | $36.4 | $78.49 |
| Long term investments | ||||
| Property, plant & equipment | $196.24 | $199.69 | $195.11 | $190.24 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $208.23 | $209.29 | $207.01 | $198.95 |
| Total investments | ||||
| Total assets | $232.09 | $242.24 | $243.41 | $277.44 |
| Current liabilities | ||||
| Accounts payable | $28.77 | $29.79 | $32.13 | $28.8 |
| Deferred revenue | ||||
| Short long term debt | $74.59 | $72.81 | $37.43 | $66.88 |
| Total current liabilities | $120.85 | $117.92 | $84.39 | $114.37 |
| Long term debt | $234.43 | $234.42 | $259.48 | $221.94 |
| Total noncurrent liabilities | $360.19 | $356.46 | $375.99 | $363.06 |
| Total debt | $309.02 | $307.22 | $296.91 | $288.81 |
| Total liabilities | $481.04 | $474.38 | $460.38 | $477.43 |
| Shareholders' equity | ||||
| Retained earnings | -$528.81 | -$499.64 | -$475.4 | -$449.96 |
| Other shareholder equity | -$5.71 | -$5.71 | -$5.67 | -$5.58 |
| Total shareholder equity | -$248.95 | -$232.14 | -$216.98 | -$199.99 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2.67 | $4.31 | $7.75 | $0.59 |
| Short term investments | ||||
| Net receivables | $8.63 | $1.26 | $1.57 | $1.82 |
| Inventory | $18.29 | $4.66 | $5.13 | $3.97 |
| Total current assets | $36.4 | $18.14 | $20.69 | $8.68 |
| Long term investments | ||||
| Property, plant & equipment | $195.11 | $182.89 | $137.56 | $112.77 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $207.01 | $188.98 | $140.14 | $116.46 |
| Total investments | ||||
| Total assets | $243.41 | $207.11 | $160.83 | $125.14 |
| Current liabilities | ||||
| Accounts payable | $32.13 | $26.17 | $16.41 | $20.74 |
| Deferred revenue | ||||
| Short long term debt | $37.43 | $49.56 | $23.04 | $59.83 |
| Total current liabilities | $84.39 | $88.28 | $65.33 | $102.23 |
| Long term debt | $259.48 | $315.93 | $168.31 | $172.68 |
| Total noncurrent liabilities | $375.99 | $320.69 | $215.74 | $207.65 |
| Total debt | $296.91 | $248.77 | $191.34 | $232.51 |
| Total liabilities | $460.38 | $408.97 | $281.07 | $309.88 |
| Shareholders' equity | ||||
| Retained earnings | -$475.4 | -$428.99 | -$321.23 | -$274.08 |
| Other shareholder equity | -$5.67 | -$5.45 | -$4.35 | -$4.11 |
| Total shareholder equity | -$216.98 | -$201.85 | -$120.24 | -$184.74 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $66.56 | $72.63 | $70.76 | $68.69 |
| Cost of revenue | $68.37 | $73.25 | $68.2 | |
| Gross Profit | -$1.81 | -$0.61 | $0.86 | $0.49 |
| Operating activities | ||||
| Research & development | $0.04 | |||
| Selling, general & administrative | $11.8 | $8.85 | $8.98 | |
| Total operating expenses | $11.8 | $8.85 | $9.82 | $9.02 |
| Operating income | -$13.61 | -$9.46 | -$8.53 | |
| Income from continuing operations | ||||
| EBIT | -$17.07 | -$12.84 | -$14.41 | |
| Income tax expense | $0.39 | $0.88 | $0.75 | -$55.31 |
| Interest expense | $11.72 | $10.51 | -$8.87 | $10.18 |
| Net income | ||||
| Net income | -$29.17 | -$24.23 | -$25.44 | $30.71 |
| Income (for common shares) | -$29.17 | -$24.23 | $30.71 | |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $186.72 | $256.51 | $211.95 | $165.56 |
| Cost of revenue | $262.05 | $204.01 | $154.53 | |
| Gross Profit | $2.02 | -$5.54 | $7.94 | $11.03 |
| Operating activities | ||||
| Research & development | $0.18 | $0.09 | $0.21 | |
| Selling, general & administrative | $28.69 | $23.68 | $16.88 | |
| Total operating expenses | $39.42 | $27.47 | $23.76 | $17.09 |
| Operating income | -$33 | -$15.82 | -$6.07 | |
| Income from continuing operations | ||||
| EBIT | -$77.94 | -$27.14 | -$14.69 | |
| Income tax expense | -$53.74 | $1.05 | -$0.13 | -$0.98 |
| Interest expense | -$32.99 | $28.77 | $20.14 | $22.94 |
| Net income | ||||
| Net income | -$46.42 | -$107.76 | -$47.15 | -$36.66 |
| Income (for common shares) | -$107.76 | -$47.15 | -$36.66 | |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | -$29.17 | -$24.23 | -$25.44 | $30.71 |
| Operating activities | ||||
| Depreciation | $2.05 | $1.8 | $1.73 | $1.75 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.98 | $2.97 | $1.44 | $1.81 |
| Total cash flows from operations | -$5.09 | -$10.28 | $33.96 | -$6.16 |
| Investing activities | ||||
| Capital expenditures | -$4.25 | -$1.68 | -$22.21 | -$8.41 |
| Investments | $9.43 | |||
| Total cash flows from investing | -$4.25 | -$1.68 | -$12.77 | -$8.41 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $10.38 | $5.55 | $7.04 | $5.86 |
| Net borrowings | -$2.24 | $5.05 | $0.46 | $10.58 |
| Total cash flows from financing | $8.14 | $10.6 | -$22.51 | $16.44 |
| Effect of exchange rate | $0.01 | $0.01 | -$0.07 | $0.33 |
| Change in cash and equivalents | -$1.2 | -$1.34 | -$1.39 | $2.2 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$46.42 | -$107.76 | -$47.15 | -$36.66 |
| Operating activities | ||||
| Depreciation | $6.93 | $5.54 | $5.45 | $4.89 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $7.66 | $6.41 | $3.93 | $0.99 |
| Total cash flows from operations | $13.82 | -$22.87 | -$20.65 | $2.48 |
| Investing activities | ||||
| Capital expenditures | -$33.12 | -$39.16 | -$26.65 | -$19.34 |
| Investments | $9.43 | $7.85 | $3.76 | $2.03 |
| Total cash flows from investing | -$23.69 | -$31.31 | -$22.89 | -$17.31 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $21.85 | $12.19 | $104.89 | $5.4 |
| Net borrowings | $17.24 | $41.44 | -$57.14 | -$4.64 |
| Total cash flows from financing | $9.09 | $53.63 | $50.7 | $14.78 |
| Effect of exchange rate | $0.05 | -$0.21 | -$0 | -$0.01 |
| Change in cash and equivalents | -$0.72 | -$0.75 | $7.16 | -$0.06 |
News
Fundamentals
| Market cap | $187.25M |
|---|---|
| Enterprise value | $496.03M |
| Shares outstanding | 45.78M |
| Revenue | $278.65M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$48.14M |
| Revenue Q/Q | 47.55% |
| Revenue Y/Y | 49.95% |
| P/E ratio | -3.89 |
|---|---|
| EV/Sales | 1.78 |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.67 |
| P/B ratio | -0.77 |
| Book/Share | -5.31 |
| Cash/Share | 0.01 |
| EPS | -$1.05 |
|---|---|
| ROA | -19.35% |
| ROE | 21.44% |
| Debt/Equity | -2.12 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.20 |
| Quick ratio | 0.11 |